How many institutions own QNCX stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own QNCX shares is 50, representing 23.1% of the company's common stock.

Who are the major shareholders selling Quince Therapeutics, Inc. stock?

N/A, in the last quarter, reduced its stake in QNCX by N/A restricting it's holding to - shares of worth nearly -. N/A also lessened N/A of the QNCX shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned QNCX shares holding by N/A last quarter which brought its holding to - shares worth -.

Investors who are buying QNCX stock?

As per its latest 13F filing, N/A increased its stake in QNCX by N/A in the last quarter. The institutional holder raised its holding to - shares having worth more than -. N/A also added N/A more shares of QNCX to its portfolio, raising its holding to - shares of worth -. N/A also increased its QNCX shares holding by N/A which brought its holding to - shares worth -.

QNCX's major insiders: who are they?

The insider with the most stakes in QNCX is EPIQ Capital Group, LLC , at the company. Additionally, QNCX stock is highly held by director Lamond David and CEO AND CHIEF MEDICAL OFFICER Thye Dirk among others.

Did an insider recently sell QNCX stock?

Company executives, directors, and other insiders own 11.12% percent of Quince Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which QNCX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include MONOHON TED.

Which insider recently purchased QNCX stock?

There have been 0 transaction(s) during the past 6-months in which Quince Therapeutics, Inc. insiders have bought stock, totalling 0 shares

How much of QNCX does insiders own?

Around 0 Quince Therapeutics, Inc. shares are held by insiders, which represents about 11.12% of QNCX stock.

Who is the insider with the largest stake?

QNCX , EPIQ Capital Group, LLC holds the largest portfolio of the company's shares. QNCX shares owned by EPIQ total nearly 2.86 million.

Which institution holds the most shares in QNCX?

N/A is the largest institutional owner in QNCX which holds - shares worth - or N/A of the total QNCX shares outstanding followed by N/A with ownership of - shares representing N/A of the QNCX ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.

Is Quince Therapeutics, Inc. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the QNCX is concerned, it is a stock which is optionable.

Is there a short position on QNCX's shares?

Number of QNCX shares short is 894.88K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding QNCX shares are there?

As of today, 53.71M shares of QNCX are outstanding.

Is there many float in QNCX stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, QNCX has 44.78M shares in float.

QNCX short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for QNCX is 4.61.

Stock Ideas

QNCX Stock Ownership Breakdown

NASDAQ : QNCX

Quince Therapeutics

$3.66

0.085+2.38%

Open: 2:55 PM

60.96

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableYes

Short Percent Of Outstanding Shares1.67

Short Percent Of Float1.87

Shares Outstanding53.71M

Shares Float44.78M

Shares Short894.88K

Short Ratio4.61

1.87%

Short % of Float

1.67%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

11.12% Percentage of Shares held by All Insiders

23.1% Percentage of Shares held by All Institutions

25.99% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
No Data

Insiders

Among the QNCX insiders holding of 11.12% of the stake in company, EPIQ CAPITAL GROUP, LLC, , holds the largest shares of 2.86M. LAMOND DAVID, director, is the second largest QNCX insider with ownership of 2.35M shares. THYE DIRK, CEO AND CHIEF MEDICAL OFFICER, stands third with possession of 843.94K shares of that stake.

Insiders	Designation	Shares Held
EPIQ CAPITAL GROUP, LLC		2.86M
LAMOND DAVID	director	2.35M
THYE DIRK	CEO AND CHIEF MEDICAL OFFICER	843.94K
HANNAH BRENDAN	CHIEF BUSINESS OFFICER AND COO	267.98K
RYAN CHARLES S.	PRESIDENT	122.46K
MONOHON TED	Chief Accounting Officer & VP	27.44K
MCLOUGHLIN MARGARET	director	8K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Aug 30, 2024	THYE DIRK	PURCHASE	0.70	77K	53.9K	843.94K
Aug 29, 2024	THYE DIRK	PURCHASE	0.69	77.5K	53.48K	766.94K
Aug 21, 2024	HANNAH BRENDAN	PURCHASE	0.61	2.28K	1.39K	267.98K
Aug 20, 2024	HANNAH BRENDAN	PURCHASE	0.61	2.5K	1.53K	262.27K
Aug 20, 2024	RYAN CHARLES S.	PURCHASE	0.65	48.39K	31.45K	122.46K
Aug 19, 2024	HANNAH BRENDAN	PURCHASE	0.58	2.16K	1.25K	259.77K
Dec 14, 2023	LAMOND DAVID	PURCHASE	1.04	22.63K	23.53K	2.35M
Dec 13, 2023	LAMOND DAVID	PURCHASE	1.00	22.63K	22.63K	2.32M
Dec 12, 2023	LAMOND DAVID	PURCHASE	1.00	300	300	2.28M
Dec 07, 2023	LAMOND DAVID	PURCHASE	1.01	19.12K	19.31K	2.28M
Dec 06, 2023	LAMOND DAVID	PURCHASE	1.02	19.12K	19.51K	2.26M
Dec 05, 2023	LAMOND DAVID	PURCHASE	1.01	19.12K	19.31K	2.24M
Dec 01, 2023	LAMOND DAVID	PURCHASE	0.94	14.38K	13.52K	2.22M
Nov 30, 2023	LAMOND DAVID	PURCHASE	0.90	14.38K	12.94K	2.21M
Nov 29, 2023	LAMOND DAVID	PURCHASE	0.98	14.38K	14.09K	2.19M
Aug 31, 2023	LAMOND DAVID	PURCHASE	1.32	41.03K	54.15K	2.18M
Aug 30, 2023	LAMOND DAVID	PURCHASE	1.31	41.03K	53.74K	2.14M
Aug 17, 2023	LAMOND DAVID	PURCHASE	1.29	24.77K	31.95K	2.1M
Aug 16, 2023	LAMOND DAVID	PURCHASE	1.29	117.35K	151.38K	2.07M
Aug 15, 2023	LAMOND DAVID	PURCHASE	1.32	107.89K	142.41K	1.95M
Aug 10, 2023	THYE DIRK	PURCHASE	1.26	88K	110.88K	448.91K
Aug 08, 2023	THYE DIRK	PURCHASE	1.24	80K	99.2K	360.91K
Aug 08, 2023	MCLOUGHLIN MARGARET	PURCHASE	1.23	8K	9.84K	8K
Aug 08, 2023	HANNAH BRENDAN	PURCHASE	1.22	71.76K	87.55K	201.56K
Mar 06, 2023	MONOHON TED	SALE	0.98	1.87K	1.83K	27.44K
Jun 12, 2020	EPIQ CAPITAL GROUP, LLC	PURCHASE	44.06	2.44K	107.51K	2.86M
Jun 11, 2020	EPIQ CAPITAL GROUP, LLC	PURCHASE	44.32	6.6K	292.51K	2.86M
May 22, 2020	EPIQ CAPITAL GROUP, LLC	PURCHASE	55.90	2.09K	116.55K	2.85M
May 21, 2020	EPIQ CAPITAL GROUP, LLC	PURCHASE	55.80	520	29.02K	2.85M
May 20, 2020	EPIQ CAPITAL GROUP, LLC	PURCHASE	58.00	5.67K	328.74K	2.85M
Aug 21, 2019	EPIQ CAPITAL GROUP, LLC	PURCHASE	24.87	420	10.44K	2.83M
Aug 20, 2019	EPIQ CAPITAL GROUP, LLC	PURCHASE	25.69	600	15.41K	2.83M
Aug 19, 2019	EPIQ CAPITAL GROUP, LLC	PURCHASE	26.50	2.1K	55.64K	2.83M
Aug 16, 2019	EPIQ CAPITAL GROUP, LLC	PURCHASE	26.37	700	18.46K	2.83M
May 10, 2019	EPIQ CAPITAL GROUP, LLC	PURCHASE	26.41	4.35K	114.88K	2.82M

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.